Joint Pain Supplement Recalled for Meloxicam Contamination

# Joint Pain Supplement Recalled for Meloxicam Contamination

123Herbals recalled Silintan capsules tainted with meloxicam, posing risks of cardiovascular events, gastrointestinal bleeding, and kidney injury.

This development has far-reaching implications for manufacturers, distributors, and consumers of food supplements in Europe. Below, we analyze the details and consequences of this important news.

Legal Background of the Recall

Recalls of food supplements are serious measures of food surveillance. They are ordered when products pose a health risk or violate applicable regulations.

Legal Foundations

The legal basis for recalls in the EU includes: - Regulation (EC) No 178/2002: General Food Law, Article 19 obliges companies to recall unsafe products - National Food Laws: Complementary national regulations for enforcement - Product Safety Directive: General product safety requirements

Reasons and Risks

The most common reasons for recalls of food supplements are:

Contamination with undeclared active substances: Particularly problematic are pharmaceutical active ingredients in products for weight loss, muscle building, or sexual performance. These can cause serious health risks.

Microbiological contamination: Contamination with bacteria, molds, or their toxins can lead to food poisoning.

Heavy metal contamination: Exceeding limits for lead, cadmium, mercury, or arsenic, especially in plant raw materials.

Allergens: Undeclared allergens pose a significant risk to allergic individuals.

Labeling deficiencies: Missing or misleading information on ingredients, dosage, or warnings.

Consequences for Manufacturers and Distributors

A recall has far-reaching consequences:

Financial Impacts - Direct costs for recall, logistics, and product destruction - Revenue losses due to product unavailability - Possible compensation claims - Fines and sanctions by authorities - Increased insurance premiums

Reputational Damage - Loss of consumer trust - Negative media coverage - Brand damage - Loss of trading partners - Difficulties launching new products

Legal Consequences - Official inspections and controls - Possible criminal investigations - Civil liability - Stricter conditions for future products

Prevention Strategies

To avoid recalls, companies should implement comprehensive quality and compliance management:

Quality Assurance - Implementation of HACCP concepts - Regular product analyses by accredited laboratories - Validation of manufacturing processes - Environmental monitoring in production areas

Supplier Management - Qualification and auditing of suppliers - Specifications with clear quality requirements - Incoming goods inspections - Traceability systems

Compliance Management - Regular review of legal compliance - Employee training - Documentation of all processes - Internal audits and controls

Practical Recommendations

For companies in the supplement industry, the following recommendations apply:

1. Immediate Assessment: Check immediately if and how your products are affected 2. Compliance Check: Conduct a comprehensive compliance check 3. Documentation: Ensure all required documents are complete and up to date 4. Expert Consultation: Consult compliance experts or lawyers if uncertain 5. Proactive Communication: Inform customers and partners transparently about changes 6. Continuous Monitoring: Stay informed about further developments

Further Information and Sources

Detailed information on this development can be found at the original source: [FoodNavigator](https://cardiovascularbusiness.com/topics/clinical/pharmaceutics/fda-announces-supplement-recall-over-risk-heart-attack-or-stroke)

For questions regarding the compliance of your products, the team at Supplement-Check.eu is available. Our tools and consulting services help you meet regulatory requirements and bring your products safely to market.

---

*This article was created by the Supplement-Check.eu news team and is based on official sources from regulatory authorities. Last update: 12.01.2026*

*Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific legal questions, please consult a specialist attorney.*